Person

Samit Hirawat

Formerly EVP, Chief Med.Offr., Drug Dev., Bristol Myers Squibb

Current S&P 500 boards
0
Current roles
0
Open-market buys
$402K
Open-market sales
$0

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

No current S&P 500 role.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

Sits alongside

People who currently share a board or management team with this person.

No current colleagues on record.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Apr 25, 2025BMYBuy4,250$47.58$202K
Feb 14, 2025BMYBuy1,823$54.84$100K
Nov 1, 2024BMYBuy1,830$54.68$100K

SEC reporting-owner ID (CIK) 1781290 · all filings on EDGAR